Growth Metrics

Pediatrix Medical (MD) Long-Term Deferred Tax (2018 - 2025)

Pediatrix Medical (MD) has disclosed Long-Term Deferred Tax for 8 consecutive years, with $187.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 80.34% to $187.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $187.3 million, a 80.34% increase, with the full-year FY2025 number at $187.3 million, up 80.34% from a year prior.
  • Long-Term Deferred Tax was $187.3 million for Q4 2025 at Pediatrix Medical, up from $79.8 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $673.6 million in Q4 2021 to a low of $56.3 million in Q2 2021.
  • A 5-year average of $136.5 million and a median of $101.8 million in 2023 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: soared 1136.59% in 2021, then crashed 61.53% in 2023.
  • Pediatrix Medical's Long-Term Deferred Tax stood at $673.6 million in 2021, then crashed by 60.31% to $267.3 million in 2022, then plummeted by 61.53% to $102.9 million in 2023, then rose by 0.98% to $103.9 million in 2024, then skyrocketed by 80.34% to $187.3 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Long-Term Deferred Tax are $187.3 million (Q4 2025), $79.8 million (Q3 2025), and $88.7 million (Q2 2025).